Cerenome, Inc. (CNSY): EBITDA
-$14.85M
Year ended 2025-12-31
-$28.85M
Trailing 12 months to 2026-09-30
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$14.85M | n/m | 2026-03-12, From 2025-01-01 |
| 2024-12-31 | -$13.82M | n/c | 2026-03-12, From 2024-01-01 |
| 2023-12-31 | -$12.69M | n/m | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | -$19.09M | n/m | 2024-03-05, From 2022-01-01 |
| 2021-12-31 | -$12.10M | n/m | 2023-02-23, From 2021-01-01 |
| 2020-12-31 | -$9.22M | n/m | 2022-02-24, From 2020-01-01 |
| 2019-12-31 | -$2.76M | n/m | 2021-02-22, From 2019-01-01 |
| 2018-12-31 | -$6.76M | n/c | 2020-03-30, From 2018-01-01 |
| 2017-12-31 | -$18.53M | n/m | 2019-03-29, From 2017-01-01 |
| 2016-12-31 | -$18.52M | n/m | 2018-03-09, From 2016-01-01 |
| 2015-12-31 | -$14.19M | n/m | 2017-03-24, From 2015-01-01 |
| 2014-12-31 | -$31.66M | n/m | 2016-03-11, From 2014-01-01 |
| 2013-12-31 | -$29.05M | n/m | 2016-03-11, From 2013-01-01 |
| 2012-12-31 | -$27.48M | n/m | 2015-03-16, From 2012-01-01 |
| 2011-12-31 | -$28.56M | n/m | 2014-03-14, From 2011-01-01 |
| 2010-12-31 | -$24.39M | n/m | 2013-03-15, From 2010-01-01 |
| 2009-12-31 | -$19.87M | n/a | 2012-09-07, From 2009-01-01 |
EBITDA at similar companies
| Company | Year ended | EBITDA | Change YoY |
|---|---|---|---|
| Cerenome, Inc. (CNSY) | 2025-12-31 | -$14.85M | n/m |
| ProPhase Labs, Inc. (PRPH) | 2025-12-31 | -$13.21M | n/m |
| China Pharma Holdings, Inc. (CPHI) | 2025-12-31 | -$1.74M | n/m |
| Immunome Inc. (IMNM) | 2025-12-31 | -$221.65M | n/m |
| Whitehawk Therapeutics, Inc. (WHWK) | 2025-12-31 | -$114.32M | n/m |
| Ovid Therapeutics Inc. (OVID) | 2025-12-31 | -$42.17M | n/m |
| Xenon Pharmaceuticals Inc. (XENE) | 2025-12-31 | -$370.53M | n/m |
| Adagene Inc. (ADAG) | 2025-12-31 | -$21.00M | n/m |
| Bolt Biotherapeutics, Inc. (BOLT) | 2025-12-31 | -$34.82M | n/m |
Compare CNSY, PRPH, CPHI, IMNM side by side · Screen every company in Pharmaceutical Preparations ↗